Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients, Hum Pathol, vol.31, pp.578-83, 2000. ,
CNS metastases in breast cancer, J Clin Oncol, vol.22, pp.3608-3625, 2004. ,
DOI : 10.1200/jco.2004.01.175
European Association of Urology. EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013, Eur Urol, vol.65, pp.124-161, 2014. ,
Prostate cancer, version 2, J Natl Compr Canc Netw, vol.12, pp.686-718, 2014. ,
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Ann Oncol, vol.26, pp.8-30, 2015. ,
Imaging of malignant bone involvement by morphologic, scintigraphic, and hybrid modalities, J Nucl Med, vol.46, pp.1356-67, 2005. ,
Bone scintigraphy and the added value of SPECT (single photon emission tomography) in detecting skeletal lesions, Q J Nucl Med, vol.45, pp.27-37, 2001. ,
Prospective evaluation of the clinical value of planar bone scans, SPECT, and (18)F-labeled NaF PET in newly diagnosed lung cancer, J Nucl Med, vol.42, pp.1800-1804, 2001. ,
Multi-field-of-view SPECT is superior to whole-body scanning for assessing metastatic bone disease in patients with prostate cancer, Tumori, vol.97, pp.629-662, 2011. ,
SPECTguided CT for evaluating foci of increased bone metabolism classified as indeterminate on SPECT in cancer patients, J Nucl Med, vol.47, pp.1102-1108, 2006. ,
The added value of multislice SPECT/CT in patients with equivocal bony metastasis from carcinoma of the prostate, Eur J Nucl Med Mol Imaging, vol.37, pp.706-719, 2010. ,
Should SPECT-CT replace SPECT for the evaluation of equivocal bone scan lesions in patients with underlying malignancies, Nucl Med Commun, vol.31, pp.659-65, 2010. ,
Differential diagnostic value of single-photon emission computed tomography/spiral computed tomography with Tc-99m-methylene diphosphonate in patients with spinal lesions, Nucl Med Commun, vol.32, pp.1194-200, 2011. ,
Diagnostic value of 99 mTc-MDP SPECT/spiral CT in assessing indeterminate spinal solitary lesion of patients without malignant history, Ann Nucl Med, vol.27, pp.460-467, 2013. ,
Bone imaging in prostate cancer: the evolving roles of nuclear medicine and radiology, Clin Transl Imaging, vol.4, pp.439-486, 2016. ,
Bone scintigraphy in breast cancer: added value of hybrid SPECT-CT and its impact on patient management, Nucl Med Commun, vol.33, pp.139-186, 2012. ,
Clinical impact of SPECT-CT on bone scintigraphy in oncology: Pattern approach, J BUON, vol.21, pp.1296-306, 2016. ,
Whole-body SPECT/CT for bone scintigraphy: diagnostic value and effect on patient management in oncological patients, Eur J Nucl Med Mol Imaging, vol.41, pp.59-67, 2014. ,
DOI : 10.1007/s00259-013-2532-6
Incremental diagnostic utility of systematic double-bed SPECT/CT for bone scintigraphy in initial staging of cancer patients, Cancer Imaging, vol.17, p.16, 2017. ,
,
, Revue Medicale Suisse, vol.295, pp.1082-1083, 2011.
Whole-Body SPECT/CT versus Planar Bone Scan with Targeted SPECT/CT for Metastatic Workup, BioMed Research International, p.7039406, 2017. ,
Prospective evaluation of planar bone scintigraphy, SPECT, SPECT/ CT, 18F-NaF PET/CT and whole body 1.5T MRI, including DWI, for the detection of bone metastases in high risk breast and prostate cancer patients: SKELETA clinical trial, Acta Oncol, vol.55, pp.59-67, 2016. ,
A prospective study comparing (99m)Tc-HDP planar bone scintigraphy and whole-body SPECT/CT with (18)F-fluoride PET/CT and (18)F-fluoride PET/MRI for diagnosing bone metastases, J Nucl Med, vol.58, pp.1778-1785, 2017. ,
Whole-body bone SPECT in breast cancer patients: the future bone scan protocol, Nuclear Medicine Communications, vol.37, pp.247-253, 2016. ,